Clinical Trial Update: Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating umbilical cord mesenchymal stem cells for type 2 diabetic nephropathy is in Phase 1/2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes with Renal Manifestations

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Type 2 Diabetes With Renal Manifestations | Phase 1, Phase 2 | Status: UNKNOWN